ATE355266T1 - Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE355266T1 ATE355266T1 AT99957636T AT99957636T ATE355266T1 AT E355266 T1 ATE355266 T1 AT E355266T1 AT 99957636 T AT99957636 T AT 99957636T AT 99957636 T AT99957636 T AT 99957636T AT E355266 T1 ATE355266 T1 AT E355266T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- pharmaceutical compositions
- compositions containing
- containing same
- new acylated
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9801396 | 1998-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE355266T1 true ATE355266T1 (de) | 2006-03-15 |
Family
ID=9522667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99957636T ATE355266T1 (de) | 1998-06-30 | 1999-06-23 | Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7157092B1 (de) |
| EP (1) | EP1091928B1 (de) |
| JP (1) | JP4699609B2 (de) |
| KR (1) | KR100766016B1 (de) |
| CN (1) | CN1168702C (de) |
| AR (1) | AR029877A1 (de) |
| AT (1) | ATE355266T1 (de) |
| AU (1) | AU761396B2 (de) |
| BR (1) | BR9911329A (de) |
| CA (1) | CA2337807C (de) |
| CZ (1) | CZ302062B6 (de) |
| DE (1) | DE69935330T2 (de) |
| DK (1) | DK1091928T3 (de) |
| EE (1) | EE04489B1 (de) |
| ES (1) | ES2284275T3 (de) |
| HU (1) | HUP0102475A3 (de) |
| PL (1) | PL195764B1 (de) |
| RU (1) | RU2223262C2 (de) |
| SK (1) | SK287073B6 (de) |
| TW (1) | TWI255808B (de) |
| WO (1) | WO2000000462A1 (de) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0102475A3 (en) * | 1998-06-30 | 2001-12-28 | Om Pharma | Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| AU1581400A (en) * | 1999-12-22 | 2001-07-03 | Om Pharma | Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| US7064217B2 (en) * | 2001-01-30 | 2006-06-20 | University Of Virginia Patent Foundation | Agonists and antagonists of sphingosine-1-phosphate receptors |
| DE60234375D1 (de) | 2001-09-14 | 2009-12-24 | Cytos Biotechnology Ag | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG |
| NZ537003A (en) | 2002-07-18 | 2008-03-28 | Cytos Biotechnology Ag | Hapten-carrier conjugates comprising virus like particles and uses thereof |
| JP5022028B2 (ja) | 2003-03-26 | 2012-09-12 | サイトス・バイオテクノロジー・アクチェンゲゼルシャフト | メラン−ａペプチドアナログ−ウイルス様粒子コンジュゲート |
| EP1755666B1 (de) | 2004-05-28 | 2010-12-15 | GlaxoSmithKline Biologicals SA | Impfstoffzusammensetzungen mit virosomen und einem saponin-adjuvans |
| GB0503337D0 (en) | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
| TW200700079A (en) | 2005-03-23 | 2007-01-01 | Glaxosmithkline Biolog Sa | Composition |
| US20070184068A1 (en) | 2005-12-14 | 2007-08-09 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| CN103251940A (zh) | 2005-12-22 | 2013-08-21 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗 |
| MX2008011360A (es) | 2006-03-09 | 2009-03-03 | Om Pharma | Compuestos inmunodulares y tratamiento de enfermedades relacionadas con la sobreproduccion de citoquinas inflamatorias. |
| EP1998802A2 (de) | 2006-03-30 | 2008-12-10 | GlaxoSmithKline Biologicals S.A. | Immunogene zusammensetzung |
| CN101466720B (zh) | 2006-06-12 | 2013-01-02 | 赛托斯生物技术公司 | 向rna噬菌体的病毒样颗粒内包装寡核苷酸的方法 |
| EP2422810B1 (de) | 2006-07-17 | 2014-10-22 | GlaxoSmithKline Biologicals s.a. | Influenzaimpfstoff |
| ES2525732T3 (es) | 2006-07-18 | 2014-12-29 | Glaxosmithkline Biologicals S.A. | Vacunas contra el paludismo |
| GB2453475B (en) | 2006-07-25 | 2011-01-19 | Secr Defence | Live vaccine strain |
| EP2433648A3 (de) | 2006-10-12 | 2012-04-04 | GlaxoSmithKline Biologicals S.A. | Impfstoff mit einem Öl-in-wasser-emulsionshilfsstoff |
| HUE031411T2 (en) | 2007-03-02 | 2017-07-28 | Glaxosmithkline Biologicals Sa | New Methods and Preparations |
| US9452209B2 (en) | 2007-04-20 | 2016-09-27 | Glaxosmithkline Biologicals Sa | Influenza vaccine |
| MX2009013949A (es) | 2007-06-26 | 2010-05-24 | Glaxosmithkline Biolog Sa | Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae. |
| EP2020240A1 (de) * | 2007-07-30 | 2009-02-04 | Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe | Verfahren und Substanzen zur Behandlung von Morbus Alzheimer |
| EP3118213A1 (de) | 2007-12-19 | 2017-01-18 | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Lösliche formen von hendra- und nipah-virus-f-glycoprotein und anwendungen davon |
| JP5711972B2 (ja) | 2007-12-24 | 2015-05-07 | アイディー バイオメディカル コーポレイション オブ ケベック | 組換えｒｓｖ抗原 |
| MX2010011412A (es) | 2008-04-16 | 2010-11-12 | Glaxosmithkline Biolog Sa | Vacuna. |
| US20110268757A1 (en) | 2008-12-03 | 2011-11-03 | Institut Pasteur | Use of phenol-soluble modulins for vaccine development |
| WO2010079081A1 (en) | 2009-01-07 | 2010-07-15 | Glaxosmithkline Biologicals S.A. | Methods for recovering a virus or a viral antigen produced by cell culture |
| GB0901411D0 (en) | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
| GB0901423D0 (en) | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
| EP2393922A1 (de) | 2009-02-06 | 2011-12-14 | GlaxoSmithKline Biologicals S.A. | Aufreinigung von virus oder viralen antigenen mittels dichtegradienten-ultrazentrifugation |
| SG2014014385A (en) | 2009-02-17 | 2014-04-28 | Glaxosmithkline Biolog Sa | Inactivated dengue virus vaccine with aluminium-free adjuvant |
| GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
| PT2445526T (pt) | 2009-06-24 | 2016-08-16 | Glaxosmithkline Biologicals Sa | Antigénios de rsv recombinantes |
| SG176807A1 (en) | 2009-06-24 | 2012-01-30 | Id Biomedical Corp Quebec | Vaccine |
| PL3178490T3 (pl) | 2009-07-15 | 2022-08-01 | Glaxosmithkline Biologicals S.A. | Kompozycje białka f rsv i sposoby ich wytwarzania |
| GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US9341623B2 (en) | 2009-09-25 | 2016-05-17 | Glaxosmithkline Biologicals Sa | Immunodiffusion assay for influenza virus |
| GB0919117D0 (en) | 2009-10-30 | 2009-12-16 | Glaxosmithkline Biolog Sa | Process |
| WO2011101332A1 (en) | 2010-02-16 | 2011-08-25 | Proyecto De Biomedicina Cima, S.L. | Compositions based on the fibronectin extracellular domain a for the treatment of melanoma |
| CA2797059A1 (en) | 2010-05-03 | 2011-11-10 | Glaxosmithkline Biologicals S.A. | Novel method |
| GB201009273D0 (en) | 2010-06-03 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel vaccine |
| SG189176A1 (en) | 2010-10-15 | 2013-05-31 | Glaxosmithkline Biolog Sa | Cytomegalovirus gb antigen |
| EP2505640A1 (de) | 2011-03-29 | 2012-10-03 | Neo Virnatech, S.L. | Impfstoffzusammensetzungen für vom Birnavirus übertragenen Krankheiten |
| ES2651143T3 (es) | 2011-05-13 | 2018-01-24 | Glaxosmithkline Biologicals Sa | Antígenos de F de prefusión del VRS |
| US20140072622A1 (en) | 2011-05-17 | 2014-03-13 | Glaxosmithkline Biologicals S.A. | Vaccine against streptococcus pneumoniae |
| CA2866582A1 (en) | 2012-03-18 | 2013-09-26 | Brigitte Desiree Alberte Colau | Method of vaccination against human papillomavirus |
| WO2014024026A1 (en) | 2012-08-06 | 2014-02-13 | Glaxosmithkline Biologicals S.A. | Method for eliciting in infants an immune response against rsv and b. pertussis |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| US10058603B2 (en) | 2013-03-15 | 2018-08-28 | Glaxosmithkline Biologicals S.A. | Vaccine |
| WO2015011254A1 (en) | 2013-07-26 | 2015-01-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of bacterial infections |
| KR20160040290A (ko) | 2013-08-05 | 2016-04-12 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 조합 면역원성 조성물 |
| WO2015028546A1 (en) | 2013-08-30 | 2015-03-05 | Glaxosmithkline Biologicals S.A. | Large scale production of viruses in cell culture |
| CN104436157A (zh) | 2013-09-23 | 2015-03-25 | 恩金生物有限公司 | 流感疫苗和治疗 |
| EP3556353A3 (de) | 2014-02-25 | 2020-03-18 | Merck Sharp & Dohme Corp. | Lipidnanopartikel-impfstoffadjuvanzien und antigenfreisetzungssysteme |
| WO2015165480A1 (en) | 2014-04-30 | 2015-11-05 | Institute For Research In Biomedicine | Human cytomegalovirus vaccine compositions and method of producing the same |
| CA2951430A1 (en) | 2014-06-13 | 2015-12-17 | Glaxosmithkline Biologicals Sa | Immunogenic combinations |
| WO2016180852A1 (en) | 2015-05-12 | 2016-11-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for preparing antigen-specific t cells from an umbilical cord blood sample |
| US20180186897A1 (en) | 2015-06-26 | 2018-07-05 | Institute For Research In Biomedicine | Novel vaccines in prevention and treatment of malaria |
| GB201614799D0 (en) | 2016-09-01 | 2016-10-19 | Glaxosmithkline Biologicals Sa | Compositions |
| WO2018162450A1 (en) | 2017-03-06 | 2018-09-13 | Fundación Para La Investigación Médica Aplicada | New inmunostimulatory compositions comprising an entity of cold inducible rna-binding protein with an antigen for the activation of dendritic cells |
| SG11201909265QA (en) | 2017-04-19 | 2019-11-28 | Inst Res Biomedicine | Plasmodium sporozoite npdp peptides as vaccine and target novel malaria vaccines and antibodies binding to |
| EP3581201A1 (de) | 2018-06-15 | 2019-12-18 | GlaxoSmithKline Biologicals S.A. | Escherichia coli o157:h7 polypeptide und verwendungen davon |
| US11911553B2 (en) * | 2018-07-06 | 2024-02-27 | Fenwal, Inc. | Systems and methods for concentrating cells with a syringe and a centrifuge |
| EP4004018A1 (de) | 2019-07-24 | 2022-06-01 | GlaxoSmithKline Biologicals SA | Modifizierte humane cytomegalovirus-proteine |
| CN112329267B (zh) * | 2020-11-26 | 2022-08-16 | 中国核动力研究设计院 | 一种基于特征线法的组合几何中子输运处理方法及装置 |
| CA3202549A1 (en) | 2020-12-02 | 2022-06-09 | Glaxosmithkline Biologicals Sa | Novel antigens |
| WO2022161598A1 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Antibodies broadly targeting coronaviruses and uses thereof |
| WO2022162012A2 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Antibodies broadly targeting coronaviruses and uses thereof |
| WO2023144665A1 (en) | 2022-01-28 | 2023-08-03 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61227586A (ja) * | 1985-03-30 | 1986-10-09 | Dai Ichi Seiyaku Co Ltd | ジサツカライド誘導体およびその塩 |
| JPS62129292A (ja) * | 1985-11-28 | 1987-06-11 | Toho Yakuhin Kogyo Kk | 生物活性を発現するリピドａ単糖類縁体 |
| US4746742A (en) * | 1985-11-28 | 1988-05-24 | Toho Yakuhin Kogyo Kabushiki Kaisha | Analogs of nonreducing monosaccharide moiety of lipid A |
| JPH0426662A (ja) * | 1990-05-23 | 1992-01-29 | Tosoh Corp | アミノ酸アシル誘導体及びその製造法 |
| DE4229877C2 (de) * | 1992-09-04 | 1994-09-15 | Max Delbrueck Centrum | Phospho- bzw. Phosphono-(N-acyl)-serine und ihre Herstellung |
| JPH06206893A (ja) * | 1992-09-07 | 1994-07-26 | Suntory Ltd | 新規なジサッカライド誘導体 |
| EP0668289A4 (de) * | 1993-09-07 | 1998-10-21 | Suntory Ltd | Disaccharid derivate. |
| ES2149340T3 (es) * | 1993-11-17 | 2000-11-01 | Om Pharma | Disacaridos de glucosamina, metodo para su preparacion, composicion farmaceutica que los comprende, y su uso. |
| HUP0102475A3 (en) * | 1998-06-30 | 2001-12-28 | Om Pharma | Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
-
1999
- 1999-06-23 HU HU0102475A patent/HUP0102475A3/hu unknown
- 1999-06-23 ES ES99957636T patent/ES2284275T3/es not_active Expired - Lifetime
- 1999-06-23 EE EEP200000791A patent/EE04489B1/xx not_active IP Right Cessation
- 1999-06-23 JP JP2000557223A patent/JP4699609B2/ja not_active Expired - Fee Related
- 1999-06-23 CN CNB998077615A patent/CN1168702C/zh not_active Expired - Fee Related
- 1999-06-23 RU RU2001102614/04A patent/RU2223262C2/ru not_active IP Right Cessation
- 1999-06-23 CZ CZ20004893A patent/CZ302062B6/cs not_active IP Right Cessation
- 1999-06-23 SK SK1887-2000A patent/SK287073B6/sk not_active IP Right Cessation
- 1999-06-23 PL PL99345040A patent/PL195764B1/pl not_active IP Right Cessation
- 1999-06-23 AU AU42848/99A patent/AU761396B2/en not_active Ceased
- 1999-06-23 DK DK99957636T patent/DK1091928T3/da active
- 1999-06-23 CA CA2337807A patent/CA2337807C/fr not_active Expired - Fee Related
- 1999-06-23 WO PCT/IB1999/001170 patent/WO2000000462A1/fr not_active Ceased
- 1999-06-23 DE DE69935330T patent/DE69935330T2/de not_active Expired - Lifetime
- 1999-06-23 AT AT99957636T patent/ATE355266T1/de not_active IP Right Cessation
- 1999-06-23 KR KR1020007015066A patent/KR100766016B1/ko not_active Expired - Fee Related
- 1999-06-23 EP EP99957636A patent/EP1091928B1/de not_active Expired - Lifetime
- 1999-06-23 BR BR9911329-5A patent/BR9911329A/pt not_active Application Discontinuation
- 1999-06-23 US US09/720,045 patent/US7157092B1/en not_active Expired - Fee Related
- 1999-06-30 AR ARP990103172A patent/AR029877A1/es active IP Right Grant
- 1999-07-30 TW TW088112968A patent/TWI255808B/zh not_active IP Right Cessation
-
2006
- 2006-02-28 US US11/363,691 patent/US20060148678A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0102475A2 (hu) | 2001-11-28 |
| HUP0102475A3 (en) | 2001-12-28 |
| EP1091928A1 (de) | 2001-04-18 |
| CA2337807C (fr) | 2012-08-21 |
| CN1306504A (zh) | 2001-08-01 |
| US20060148678A1 (en) | 2006-07-06 |
| AU4284899A (en) | 2000-01-17 |
| EE04489B1 (et) | 2005-06-15 |
| DK1091928T3 (da) | 2007-07-23 |
| RU2223262C2 (ru) | 2004-02-10 |
| EP1091928B1 (de) | 2007-02-28 |
| ES2284275T3 (es) | 2007-11-01 |
| TWI255808B (en) | 2006-06-01 |
| CZ20004893A3 (en) | 2001-05-16 |
| AR029877A1 (es) | 2003-07-23 |
| BR9911329A (pt) | 2001-10-16 |
| KR20010083078A (ko) | 2001-08-31 |
| PL345040A1 (en) | 2001-11-19 |
| DE69935330D1 (de) | 2007-04-12 |
| US7157092B1 (en) | 2007-01-02 |
| CZ302062B6 (cs) | 2010-09-22 |
| AU761396B2 (en) | 2003-06-05 |
| SK18872000A3 (sk) | 2001-07-10 |
| CA2337807A1 (fr) | 2000-01-06 |
| DE69935330T2 (de) | 2007-10-31 |
| CN1168702C (zh) | 2004-09-29 |
| WO2000000462A1 (fr) | 2000-01-06 |
| KR100766016B1 (ko) | 2007-10-11 |
| PL195764B1 (pl) | 2007-10-31 |
| EE200000791A (et) | 2002-02-15 |
| JP2002519338A (ja) | 2002-07-02 |
| SK287073B6 (sk) | 2009-11-05 |
| JP4699609B2 (ja) | 2011-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355266T1 (de) | Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69902535D1 (de) | Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen | |
| ATE296823T1 (de) | Substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| ATE252562T1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE235507T1 (de) | Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| ATE234291T1 (de) | Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung | |
| ATE219069T1 (de) | Neue arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| ATE279392T1 (de) | Indol-verbindungen, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre medizinische anwendung | |
| DE69625923D1 (de) | Oxidmaterialien, verfahren zur dessen herstellung und diese materialien enthaltende katalysatorzusammensetzungen | |
| ATE252542T1 (de) | Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen,die diese enthalten | |
| ATE323092T1 (de) | Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE143010T1 (de) | Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE209219T1 (de) | Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69933307D1 (de) | Fliessfähige, wässrige borhaltige zusammensetzungen und verfahren zu ihrer herstellung | |
| DE60022890D1 (de) | Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen | |
| DE60010113D1 (de) | N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
| ATE222586T1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE313524T1 (de) | 1,1- and 1,2-disubstituierte cyclopropane, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen | |
| ATE226082T1 (de) | Pharmazeutische zusammensetzungen aus dalfopristine und quinupristine und verfahren zu ihrer herstellung | |
| DE69421182D1 (de) | Neue clathrat-verbindungen, verfahren zu ihrer herstellung und fäulmisverhinderndes mittel | |
| ATE244246T1 (de) | Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DE69630873D1 (de) | Propylen-1-penten copolymerisate, verfahren zu deren herstellung und zusammensetzungen diese enthaltend | |
| DE59909123D1 (de) | Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung | |
| ATE248171T1 (de) | Isoindoloindolon-derivate, verfahren zu ihrer herstellung und die enthaltende pharmazeutische zusammensetzungen | |
| ATE275136T1 (de) | Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |